Identification of drug-induced hyper- or hypoprolactinemia in the female rat based on general and reproductive toxicity study parameters.

Birth Defects Res B Dev Reprod Toxicol

GlaxoSmithKline, King of Prussia, Pennsylvania 19406-0939, USA.

Published: June 2007

Observations associated with drug-induced hyper- or hypoprolactinemia in rat toxicology studies may be similar and include increased ovarian weight due to increased presence of corpora lutea. Hyperprolactinemia may be distinguished if mammary gland hyperplasia with secretion and/or vaginal mucification is observed. Reproductive toxicity study endpoints can differentiate hyper- from hypoprolactinemia based on their differential effects on estrous cycles, mating, and fertility. Although the manifestations of hyper- and hypoprolactinemia in rats generally differ from that in humans, mechanisms of drug-related changes in prolactin synthesis/release can be conserved across species and pathologically increased or decreased prolactin levels may compromise some aspect of reproductive function in all species.

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdrb.20126DOI Listing

Publication Analysis

Top Keywords

hyper- hypoprolactinemia
16
drug-induced hyper-
8
reproductive toxicity
8
toxicity study
8
identification drug-induced
4
hyper-
4
hypoprolactinemia
4
hypoprolactinemia female
4
female rat
4
rat based
4

Similar Publications

Article Synopsis
  • Hyper and hypoprolactinemia are linked to metabolic changes in patients with PCOS, with prolactin levels having a protective effect against metabolic issues like insulin resistance and obesity.
  • Four studies specifically looked at hypoprolactinemia in PCOS, while six additional studies reported low prolactin levels, though the overall prevalence is relatively low (13.2-13.9%).
  • There is a need for more research, including prospective studies and clinical trials, to explore treatments targeting both high and low prolactin levels in PCOS patients.
View Article and Find Full Text PDF

Purpose: Hypo- and hyper-prolactinemia have deleterious effects on male reproduction, yet there is a dearth of information regarding the underlying mechanisms. The aim of this study was to delineate the molecular mechanisms by which hypo- and hyper-prolactinemia affects spermatogenesis and fertility in male rats.

Methods: In vivo male rat models for hypo- and hyper-prolactinemia were established using dopamine receptor agonist, Bromocriptine (Brm), and antagonist, Fluphenazine (Flu), respectively.

View Article and Find Full Text PDF

Prolactin effects on the pathogenesis of diabetes mellitus.

Eur J Clin Invest

June 2024

Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Università Federico II di Napoli, Naples, Italy.

Background: Prolactin (PRL) is a pituitary hormone promoting lactation in response to the suckling reflex. Beyond its well-known effects, novel tissue-specific and metabolic functions of PRL are emerging.

Aims: To dissect PRL as a critical mediator of whole-body gluco-insulinemic sensitivity.

View Article and Find Full Text PDF

Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile.

J Endocrinol Invest

December 2023

Andrology, Women's Endocrinology and Gender Incongruence Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.

Purpose: Data on the role of prolactin (PRL) in the physiologic range in the female sexual response are scanty. We aimed at investigating the association between PRL and sexual function as assessed by the Female Sexual Function Index (FSFI). We explored the presence of a cut-off level of PRL able to identify Hypoactive Sexual Desire Disorder (HSDD).

View Article and Find Full Text PDF

Background: Various studies, mainly conducted in adults, have examined the hormonal axis in primary empty sella (PES), and reported various forms of pituitary deficiencies. We report our experience with PES in pediatric patients in terms of pituitary function, associated impairments, and responses to treatment.

Methods: We reviewed 10,560 cranial and 325 pituitary magnetic resonance imagings (MRIs) performed at our university hospital between January 2010 and December 2020 and identified patients with PES.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!